Industries > Pharma > Global Tuberculosis Treatment Drugs Market Report 2020-2030

Global Tuberculosis Treatment Drugs Market Report 2020-2030

Forecasts & Analysis of Epidemiology by Regions (United States, Europe, Germany, France, Italy, Spain, UK, Japan & Rest of the World), by Regional Markets (North America, Latin America, Middle East & Africa, Asia & Asia Pacific), Plus Analysis of Leading Nations, by Therapies & Leading Companies

PUBLISHED: 01 April 2020
PAGES: 174
PRODUCT CODE: PHA0733
SUBMARKET: Therapeutic Drugs

Clear
WOOCS 2.2.1
SKU: PHA0733 Categories: , Tag:

Tuberculosis (TB) is a major public health concern worldwide, with an estimated 10.0 million cases of tuberculosis in 2019, a number that has been relatively stable in recent years. It is interesting to see how WHO, and global companies have taken steps to end tuberculosis worldwide. The growing number of prevalence cases of Multi-Drug Resistant TB and cases of new and relapsed TB among the population of developing and under developing countries have.

Not only the development from the treatment point of view, but also the new development diagnostic tests will play an important role in shifting the dynamics of the tuberculosis market. More than 23 companies have formed an alliance with institutions in developing markets to support clinical therapeutic developments.

The Tuberculosis Treatment Drugs Market is growing at the noteworthy CAGR of 5.8% with the estimated market size of $1,080 million in 2020. Globally market is registered to grow at the CAGR of 5.8% from 2019 to 2020. Growing needs of anti-tuberculosis drugs, increase in multi drug resistance TB cases, government initiatives towards TB elimination and the increase in the pipeline drugs as well as the vaccines will drive the growth of the TB market from 2020 to 2030. In addition, increase in funding will further boost up the institutes and the companies for research in the high TB burden countries.

The Tuberculosis Treatment Drugs Market Report explains the findings of the research of the Tuberculosis treatment market developments and growth factors which is driving the market. It notes key findings and makes recommendations for action for the companies who are actively participating and involved in the R&D of the tuberculosis therapies.

Global Tuberculosis Treatment Drugs Market Report 2020-2030

• Understand the dynamics of TB market
• Epidemiology Forecast and Analysis Globally and Regionally
• Market Forecast & Analysis by Regions, By Nations, By Therapies & By Companies
• Promising Therapies in the pipeline
• Shift from generics to the effective TB therapies
• WHO initiatives to end Global TB
• Growing demand of effective therapies in developed/ developing countries
• High TB Burden countries and funding appropriations
• Effective Diagnostic Tests recently launched & under development

Leading Companies in the Tuberculosis Drugs Market:
• Johnson & Johnson
• Lupin Limited
• Macleods Pharmaceuticals Limited
• Pfizer
• Otsuka Pharmaceuticals

Buy our report today Global Tuberculosis Treatment Drugs Market Report 2020-2030: Forecasts & Analysis of Epidemiology by Regions (United States, Europe, Germany, France, Italy, Spain, UK, Japan & Rest of the World), by Regional Markets (North America, Latin America, Middle East & Africa, Asia & Asia Pacific), Plus Analysis of Leading Nations, by Therapies & Leading Companies. Avoid missing out by staying informed – order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Global Tuberculosis Treatment Drugs Market Report 2020-2030


Download sample pages

Complete the form below to download your free sample pages for Global Tuberculosis Treatment Drugs Market Report 2020-2030


Latest Pharma news

Visiongain Publishes Generic Drugs Market Report 2020-2030

The 431-page report provides clear detailed insight into the generic drugs market. Discover the key drivers and challenges affecting the market.

03 July 2020

READ

Visiongain publishes Clinical Workflow Solutions Market Report 2020-2030

Where is the Clinical Workflow Solutions market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there.

03 July 2020

READ

Visiongain Publishes Clinical Trials Market Report 2020-2030

With the growing burden of rare diseases around the world, there has been a rise and advancement in the therapy development of these types of diseases. While the fact remains that over 90% of these diseases lack approval for treatment and the total number of terminal rare diseases to receive the first treatment every year remains low.

01 July 2020

READ

Visiongain Publishes Clinical Risk Grouping Solutions Market Report 2020-2030

The market growth is attributed to the growing adoption of big data and AI in data management and monitoring of clinical information in health care.

01 July 2020

READ

Categories

Category